You have read all your free articles, to continue reading subscribe to read the rest of this content.
Together with LTS Lohmann Therapie-Systeme the company will start the first-ever clinical trial of microarray patches for the local intradermal treatment of psoriasis. The study will start in April 2019 with expected completion later this year and the aim of the study is to document safety and efAlready a subscriber…
In order to increase the scientific value of the research on preventative treatment with the Diamyd® diabetes vaccine, the research team at Lund University, who have been driving the DiAPREV-IT study since 2009, decided to expand the dataset with additional children at high risk of presenting with Already a subscriber…
Hansa Biopharma has announced positive data from an investigator-initiated phase 2 trial that evaluated safety, tolerability and efficacy of imlifidase in 15 patients with severe anti-GBM antibody disease. Anti-GBM antibody disease, also known as Goodpasture’s disease, is a severe autoimmune diAlready a subscriber Login You have read all your free…
The company announces that the first patient has been enrolled in study evaluating the efficacy of digital therapeutic modia in combination with sublingual buprenorphine/ naloxone for the treatment of opioid use disorder. The randomized, open-label, parallel-group study will evaluate whether the Already a subscriber Login You have read all your…
